Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 03 > 20
Other dates of the month:
- Bank of France head says French banks stable, welcomes Credit Suisse deal -Le Monde
- CancerVAX CEO Ryan Davies Sits Down with Oncology Research Leader
- Equinor ASA: Buy-back of shares to share programmes for employees
- Global Enterprise Data Management Market Size & Analysis
- Centrais Elétricas Brasileiras S.A. – Eletrobrás (NYSE:EBR) Q4 2022 Earnings Call Transcript
- HireQuest, Inc. (NASDAQ:HQI) Q4 2022 Earnings Call Transcript
- Groupon, Inc. (NASDAQ:GRPN) Q4 2022 Earnings Call Transcript
- Splenic Tyrosine Kinase SYK Inhibitors Market Clinical Trials Companies Insight
- Sarcos Technology and Robotics Corporation (NASDAQ:STRC) Q4 2022 Earnings Call Transcript
- Coda Octopus Group, Inc. (NASDAQ:CODA) Q1 2023 Earnings Call Transcript
- Lizhi Inc. (NASDAQ:LIZI) Q4 2022 Earnings Call Transcript
- Should You Hold Omnicell (OMCL)?
- Blue Apron Holdings, Inc. (NYSE:APRN) Q4 2022 Earnings Call Transcript
- Gladiator Metals Enters into Binding Drilling Contract
- LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript
- HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript
- Investors Will Want Malaysia Marine and Heavy Engineering Holdings Berhad's (KLSE:MHB) Growth In ROCE To Persist
- Global Horticulture LED Lighting Market Size & Analysis
- GLOBAL MARKETS-Stocks slide as Credit Suisse rescue fails to stem rout
- US funding stress metric hits three-month high as crisis rattles regional banks
- Comstock Inc. (AMEX:LODE) Q4 2022 Earnings Call Transcript
- C-arm Market to hit USD 3.2 Billion by 2032, says Global Market Insights Inc.
- Exor N.V.: Periodic Report on the Buyback Program
- Macro-Economic Factors Pressured Tyler Technologies (TYL) Stock in Q4
- What Makes Entegris (ENTG) an Attractive Investment?
- At UK£0.92, Is Gear4music (Holdings) plc (LON:G4M) Worth Looking At Closely?
- Investors punish UBS after Credit Suisse rescue, shares plummet
- Global Oncolytic Virus Therapy Clinical Pipeline Insight 2028
- Opcom Holdings Berhad's (KLSE:OPCOM) investors will be pleased with their impressive 183% return over the last three years
- New Zealand's foreign minister to visit counterpart in China
- Euro zone bond yields drop as contagion risk spooks investors
- Credit Suisse tells staff to keep working and that salary and bonus will be paid 'as previously communicated' after UBS takeover deal: reports
- Dow futures rise 20 pts; banking sector tensions remain
- UPDATE 2-CF Industries to buy Incitec Pivot's U.S. ammonia plant in $1.68 bln deal
- Leafly Holdings, Inc. (NASDAQ:LFLY) Q4 2022 Earnings Call Transcript
- New York City REIT, Inc. (NYSE:NYC) Q4 2022 Earnings Call Transcript
- Ukraine: Volunteer specialist doctors run clinics near front
- KE Holdings Inc. (NYSE:BEKE) Q4 2022 Earnings Call Transcript
- Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q4 2022 Earnings Call Transcript
- Williams-Sonoma, Inc. (NYSE:WSM) Q4 2022 Earnings Call Transcript
- Hello Group Inc. (NASDAQ:MOMO) Q4 2022 Earnings Call Transcript
- Transactions in connection with share buyback programme
- Nasdaq Stockholm Celebrates its 160th Anniversary
- NewHydrogen Names Steven Hill as Vice President
- SolGold PLC Announces Appointment of CFO and CEO
- Atlantic Lithium Limited Announces 2023 Exploration and Resource Programmes Update
- Signet Jewelers Limited (NYSE:SIG) Q4 2023 Earnings Call Transcript
- UPDATE 1-French banks stable, Credit Suisse takeover deal welcome -Bank of France head
- Janus International Group, Inc. (NYSE:JBI) Q4 2022 Earnings Call Transcript
- Neurometabolic Disorders Market Is Expected to rise at A CAGR Of 5.2% during the forecast period 2022 to 2030: Growth Plus Reports